|
| 37424414 | Does Post-traumatic Stress Disorder Impact Treatment Outcomes within a Randomised Controlled Trial of Mitochondrial Agents for Bipolar Depression? | | 2023 |
| 37713568 | Comorbidity between major depressive disorder and physical diseases: a comprehensive review of epidemiology, mechanisms and management. | World Psychiatry | 2023 |
| 37964558 | The Influence of Personality Disorder Symptoms on Treatment Outcomes in Bipolar Disorder: A Secondary Analysis of a Randomised Controlled Trial. | | 2023 |
| 37681420 | Psychiatric sequelae after SARS-Cov-2 infection: trajectory, predictors and associations in a longitudinal Australian cohort. | | 2023 |
| 37347392 | Exploratory study of ultraviolet B (UVB) radiation and age of onset of bipolar disorder. | Int J Bipolar Disord | 2023 |
| 37406796 | Equal remission rates and reduced length of hospital stay with twice-daily repetitive transcranial magnetic stimulation (rTMS) for major depression - A large naturalistic retrospective cohort association study. | | 2023 |
| 36867224 | Results of the COVID-19 mental health international for the health professionals (COMET-HP) study: depression, suicidal tendencies and conspiracism. | Soc Psychiatry Psychiatr Epidemiol | 2023 |
| 37119225 | The Impact of -acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analysis of Participant Change during a 12-week Randomised Controlled Trial. | | 2023 |
| 34758422 | Results of the COVID-19 mental health international for the general population (COMET-G) study. | Eur Neuropsychopharmacol | 2022 |
| 35839639 | The effect of different degrees of lockdown and self-identified gender on anxiety, depression and suicidality during the COVID-19 pandemic: Data from the international COMET-G study. | Psychiatry Res | 2022 |
| 35811423 | Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy. | CNS Spectrums | 2022 |
| 35932492 | Association between polarity of first episode and solar insolation in bipolar I disorder. | J Psychosom Res | 2022 |
| 36191545 | The role of metformin as a treatment for neuropsychiatric illness. | European Neuropsychopharmacology | 2022 |
| 35466101 | Mixed Methods Thematic Analysis of a Randomised Controlled Trial of Adjunctive Mitochondrial Agents for Bipolar Depression. | Clinical Psychopharmacology and Neuroscience | 2022 |
| 33949291 | Cognition-immune interactions between executive function and working memory, tumour necrosis factor-alpha (TNF-alpha) and soluble TNF receptors (sTNFR1 and sTNFR2) in bipolar disorder. | World Journal of Biological Psychiatry | 2022 |
| 34259318 | Cognitive Profile and Relationship with Quality of Life and Psychosocial Functioning in Mood Disorders. | Archives of Clinical Neuropsychology | 2022 |
| 34800584 | Does metabolic syndrome or its component factors alter the course of bipolar disorder? A systematic review. | Neurosci Biobehav Rev | 2022 |
| 35143668 | Effect of Glucocorticoid and 11β-Hydroxysteroid-Dehydrogenase Type 1 (11β-HSD1) in Neurological and Psychiatric Disorders. | International Journal of Neuropsychopharmacology | 2022 |
| 34757312 | A placebo-controlled, randomised pilot trial of N-acetylcysteine or placebo for cessation of tobacco smoking. | European Neuropsychopharmacology | 2021 |
| 34295268 | The Role of Mitochondria in Mood Disorders: From Physiology to Pathophysiology and to Treatment. | Front Psychiatry | 2021 |
| 34265321 | Statins: Neurobiological underpinnings and mechanisms in mood disorders. | Neurosci Biobehav Rev | 2021 |
| 34211410 | The Effect of Adjunctive Mangosteen Pericarp on Cognition in People With Schizophrenia: Secondary Analysis of a Randomized Controlled Trial. | Frontiers in Psychiatry | 2021 |
| 33831461 | Risk of cancer in bipolar disorder and the potential role of lithium: International collaborative systematic review and meta-analyses. | Neurosci Biobehav Rev | 2021 |
| 33726522 | Synthesizing the Evidence for Ketamine and Esketamine in Treatment-Resistant Depression: An International Expert Opinion on the Available Evidence and Implementation. | Am J Psychiatry | 2021 |
| 33504953 | Effects of aspirin on the long-term management of depression in older people: a double-blind randomised placebo-controlled trial. | Mol Psychiatry | 2021 |
| 33651412 | Age as a predictor of quit attempts and quit success in smoking cessation: findings from the International Tobacco Control Four-Country survey (2002-14). | Addiction | 2021 |
| 33153268 | The effect of concomitant benzodiazepine use on neurocognition in stable, long-term patients with bipolar disorder. | Australian and New Zealand Journal of Psychiatry | 2021 |
| 33031817 | Trace Amine-Associated Receptor 1 (TAAR1): A new drug target for psychiatry? | Neuroscience and Biobehavioral Reviews | 2021 |
| 33289425 | A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough? | World J Biol Psychiatry | 2021 |
| 34467430 | Variations in seasonal solar insolation are associated with a history of suicide attempts in bipolar I disorder. | Int J Bipolar Disord | 2021 |
| 32848956 | Editorial: Placebo and Nocebo Effects in Psychiatry and Beyond. | Frontiers in Psychiatry | 2020 |
| 31775518 | Physical Activity as a Predictor of Clinical Trial Outcomes in Bipolar Depression: A Subanalysis of a Mitochondrial-Enhancing Nutraceutical Randomized Controlled Trial. | Canadian Journal of Psychiatry | 2020 |
| 31661974 | Diet quality, dietary inflammatory index and body mass index as predictors of response to adjunctive -acetylcysteine and mitochondrial agents in adults with bipolar disorder: A sub-study of a randomised placebo-controlled trial. | Australian and New Zealand Journal of Psychiatry | 2020 |
| 32492080 | Effect of Aspirin vs Placebo on the Prevention of Depression in Older People: A Randomized Clinical Trial. | JAMA Psychiatry | 2020 |
| 32600481 | Interleukin-6 and total antioxidant capacity levels following -acetylcysteine and a combination nutraceutical intervention in a randomised controlled trial for bipolar disorder. | Acta Neuropsychiatrica | 2020 |
| 30878786 | Association between solar insolation and a history of suicide attempts in bipolar I disorder. | J Psychiatr Res | 2019 |
| 31551825 | Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders. | Frontiers in Psychiatry | 2019 |
| 29931798 | A randomized controlled trial of MoodSwings 2.0: An internet-based self-management program for bipolar disorder. | Bipolar Disorders | 2019 |
| 29926533 | Incidence and characteristics of the nocebo response from meta-analyses of the placebo arms of clinical trials of olanzapine for bipolar disorder. | Bipolar Disorders | 2019 |
| 30496692 | Considerations when selecting pharmacotherapy for nicotine dependence. | Expert Opinion on Pharmacotherapy | 2019 |
| 30328970 | Efficacy of adjunctive Garcinia mangostana Linn (mangosteen) pericarp for bipolar depression: study protocol for a proof-of-concept trial. | Revista Brasileira de Psiquiatria | 2019 |
| 30918489 | The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia. | Frontiers in Psychiatry | 2019 |
| 31500670 | N-acetylcysteine for cessation of tobacco smoking: rationale and study protocol for a randomised controlled trial. | Trials | 2019 |
| 30690898 | Putative neuroprotective pharmacotherapies to target the staged progression of mental illness. | Early Intervention in Psychiatry | 2019 |
| 30905130 | Protocol and Rationale: A 24-week Double-blind, Randomized, Placebo Controlled Trial of the Efficacy of Adjunctive Linn. (Mangosteen) Pericarp for Schizophrenia. | Clinical Psychopharmacology and Neuroscience | 2019 |
| 30678686 | A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo. | BMC Medicine | 2019 |
| 30771791 | Correction to: A randomised controlled trial of a mitochondrial therapeutic target for bipolar depression: mitochondrial agents, N-acetylcysteine, and placebo. | BMC Medicine | 2019 |
| 26542332 | Youth Depression Alleviation-Augmentation with an anti-inflammatory agent (YoDA-A): protocol and rationale for a placebo-controlled randomized trial of rosuvastatin and aspirin. | Early Intervention in Psychiatry | 2018 |
| 28984491 | Monitoring for antidepressant-associated adverse events in the treatment of patients with major depressive disorder: An international consensus statement. | World J Biol Psychiatry | 2018 |
| 30555363 | Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0. | Front Psychiatry | 2018 |